Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
MBX Biosciences
4178
MBX Biosciences
Health Care
Technology
Biotechnology
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Suggest edits
Founded
2019
Raised
$34.6M
Follow us
Companies in the same industry
EnBiotix, Inc.
Prevnos
Tetra Discovery Partners, Inc.
Palisade Therapeutics
Pionyr Immunotherapeutics
Arcturus Therapeutics
Cytena
Partner Therapeutics
Suzhou Zelgen Biopharmaceuticals
Kronos Bio Inc
Overview
Funding
1
Add info
Latest funding
$34,600,000
Venture capital (Series A) - 2020
Frazier Healthcare Partners
OrbiMed
BioCrossroads
+3
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$34,600,000
Venture capital (Series A)
FinSMEs
MBX Biosciences Closes $34.6M Series A Financing
